EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease

Lingyun Zhou, Chang-Hai Liu, Duoduo Lv, Klarke Michael Sample, Ángela Rojas, Yugu Zhang, Huandi Qiu, Linye He, Li Zheng, Liyu Chen, Binru Cai, Yiguo Hu und 1 weitere

Cell Reports · 2025-04 · 44 (4) · 115457

DOI: 10.1016/j.celrep.2025.115457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-04. Verfasst von Lingyun Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China. Electronic address: lingyunzhou@scu.edu.cn. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B virus, Hepatitis B. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Province Science and Technology Support Program, Innovative Health Initiative, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis B virusHepatitis BHumansAnimalsHepatic Stellate CellsMiceLiver CirrhosisPoly (ADP-Ribose) Polymerase-1HepatocytesNicotinamide PhosphoribosyltransferaseCytokinesSignal Transduction

Stichwörter der Autor:innen

CP: CancerCP: MicrobiologyPARP1 lactylationhepatic stellate cellsliver fibrosissingle-cell RNA sequencingtelomere maintenance mechanisms

Substanzen

Poly (ADP-Ribose) Polymerase-1Nicotinamide PhosphoribosyltransferaseCytokinesPARP1 protein, human

Autor:innen und Institutionen

  • Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China. Electronic address: lingyunzhou@scu.edu.cn.
  • Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
  • SeLiver Group, Institute of Biomedicine of Seville (HUVR/CSIC/US), Department of Medicine, University of Seville, Seville, Spain; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain; UCM Digestive Diseases, Virgen de…
  • Thoracic Oncology Ward, Cancer Center, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, China.
  • Thyroid and Parathyroid Surgery Center, West China Hospital of Sichuan University, Chengdu, China.

Förderung

  • Sichuan Province Science and Technology Support Program
  • Innovative Health Initiative
  • Carlos III Health Institute
  • National Natural Science Foundation of China
  • Sichuan University

Zitieren

APA

Zhou, L., Liu, C. H., Lv, D., Sample, K. M., Rojas, Á., Zhang, Y., Qiu, H., He, L., Zheng, L., Chen, L., Cai, B., Hu, Y., & Romero-Gómez, M. (2025). Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease. Cell Reports, 44(4), 115457. https://doi.org/10.1016/j.celrep.2025.115457

Vancouver

Zhou L, Liu CH, Lv D, Sample KM, Rojas Á, Zhang Y, et al. Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease. Cell Reports. 2025;44(4):115457. doi:10.1016/j.celrep.2025.115457

BibTeX
@article{Zhou2025,
  author = {Zhou, Lingyun and Liu, Chang-Hai and Lv, Duoduo and Sample, Klarke Michael and Rojas, Ángela and Zhang, Yugu and Qiu, Huandi and He, Linye and Zheng, Li and Chen, Liyu and Cai, Binru and Hu, Yiguo and Romero-Gómez, Manuel},
  title = {Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {4},
  pages = {115457},
  doi = {10.1016/j.celrep.2025.115457}
}
Kostenlos starten →